Dr. Sergiu Pașcă

So I've been traveling around the world trying to find most patients with Timothy syndrome, even try to understand the complexity of the disease, the severity of the disease.

And so we now have a large cohort of the patients ready and we're preparing for the first clinical trial.

We already started producing the drug.

So it's druggable.

We think that it's druggable, but this will be the first therapeutic.

for a psychiatric disease that has been exclusively developed with human stem cell models without anything else, you know.

I like to joke about it.

Probably you knew very well Luber's dryer.

He would bring coffee by.

He had our office.

across our D222, right?

So he would come at night.

It's Stryer.

That's what it is.

I mean, he was an amazing communicator.

I think above anything, he was just a larger than life figure who like be able to like go with you in a conversation from like a deep molecular mechanism to what does it actually mean?

Yeah, very kind person too.

So my last conversation with Lubert, which happened...

I think a month before he passed away, he came to my office at Stanford.

We would meet like every few months.